Gadgeel S - Search Results

1

Phase I study of bryostatin 1 and gemcitabine.

El-Rayes BF, Gadgeel S, Shields AF, Manza S, Lorusso P, Philip PA. El-Rayes BF, et al. Among authors: gadgeel s. Clin Cancer Res. 2006 Dec 1;12(23):7059-62. doi: 10.1158/1078-0432.CCR-06-1419. Clin Cancer Res. 2006. PMID: 17145828 Clinical Trial.

2

A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.

Philip PA, Zalupski MM, Gadgeel S, Hussain M, Shields A. Philip PA, et al. Among authors: gadgeel s. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-86-S19-88. Semin Oncol. 1997. PMID: 9427274 Clinical Trial.

3

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.

Hussain M, Gadgeel S, Kucuk O, Du W, Salwen W, Ensley J. Hussain M, et al. Among authors: gadgeel s. Cancer. 1999 Dec 1;86(11):2364-9. Cancer. 1999. PMID: 10590379 Clinical Trial.

4

Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer.

Gadgeel SM, Shields AF, Heilbrun LK, Labadidi S, Zalupski M, Chaplen R, Philip PA. Gadgeel SM, et al. Am J Clin Oncol. 2003 Feb;26(1):37-41. doi: 10.1097/00000421-200302000-00008. Am J Clin Oncol. 2003. PMID: 12576922 Clinical Trial.

5

A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" design.

Gadgeel SM, Boinpally RR, Heilbrun LK, Wozniak A, Jain V, Redman B, Zalupski M, Wiegand R, Parchment R, LoRusso PM. Gadgeel SM, et al. Invest New Drugs. 2003 Feb;21(1):63-74. doi: 10.1023/a:1022972427532. Invest New Drugs. 2003. PMID: 12795531 Free article. Clinical Trial.

6

Cost-effectiveness and lung cancer clinical trials.

Du W, Reeves JH, Gadgeel S, Abrams J, Peters WP. Du W, et al. Among authors: gadgeel s. Cancer. 2003 Oct 1;98(7):1491-6. doi: 10.1002/cncr.11659. Cancer. 2003. PMID: 14508837 Free article.

7

Novel combinations using pemetrexed in malignant mesothelioma.

Gadgeel SM, Pass HI. Gadgeel SM, et al. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. doi: 10.3816/clc.2004.s.005. Clin Lung Cancer. 2004. PMID: 15117427 Review.

8

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies.

Lorusso PM, Adjei AA, Varterasian M, Gadgeel S, Reid J, Mitchell DY, Hanson L, DeLuca P, Bruzek L, Piens J, Asbury P, Van Becelaere K, Herrera R, Sebolt-Leopold J, Meyer MB. Lorusso PM, et al. Among authors: gadgeel s. J Clin Oncol. 2005 Aug 10;23(23):5281-93. doi: 10.1200/JCO.2005.14.415. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009947 Clinical Trial.

9

Phase I clinical trial of BMS-247550, a derivative of epothilone B, using accelerated titration 2B design.

Gadgeel SM, Wozniak A, Boinpally RR, Wiegand R, Heilbrun LK, Jain V, Parchment R, Colevas D, Cohen MB, LoRusso PM. Gadgeel SM, et al. Clin Cancer Res. 2005 Sep 1;11(17):6233-9. doi: 10.1158/1078-0432.CCR-05-0127. Clin Cancer Res. 2005. PMID: 16144926 Clinical Trial.

10

A phase I study of flavopiridol and docetaxel.

El-Rayes BF, Gadgeel S, Parchment R, Lorusso P, Philip PA. El-Rayes BF, et al. Among authors: gadgeel s. Invest New Drugs. 2006 Jul;24(4):305-10. doi: 10.1007/s10637-005-4343-5. Invest New Drugs. 2006. PMID: 16683073 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters